ABP-dHC-CecropinA-K(24)

General Information


DRACP ID  DRACP00672

Peptide Name   ABP-dHC-CecropinA-K(24)

Sequence  RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK

Sequence Length  37

UniProt ID  Not available

PubChem CID  Not available

Origin  ABP-dHC-Cecropin A and its analog

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia Leukemia IC50=184.9 µM MTT assay 24h 1
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia IC50=223.9 µM MTT assay 24h 1
THP-1 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia IC50=196.1 µM MTT assay 24h 1

Hemolytic Activity  Human red blood cells (hRBCs): only 3% hemolysis was observed at the concentration of 800 µM

Normal (non-cancerous) Cytotoxicity  HEK-293, PBMCs: no cytotoxicity toward HEK-293 cells or PBMCs, even at the highest concentration of 640 µM.

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00672

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C186H321N57O46

Absent amino acids  CHMPSY

Common amino acids  K

Mass  473429

Pl  11.86

Basic residues  10

Acidic residues  2

Hydrophobic residues  16

Net charge  8

Boman Index  -5562

Hydrophobicity  -24.86

Aliphatic Index  108.11

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  152.78

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28347740

Title  Selective cytotoxicity of the antibacterial peptide ABP-dHC-Cecropin A and its analog towards leukemia cells

Doi 10.1016/j.ejphar.2017.03.054

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.